…Background Immune checkpoint inhibitors (ICIs) have transformed the management of stage III melanoma, offerin…
Immune Checkpoint Inhibitors
This drug is selected. Its supporting articles are shown below.
Articles mentioning Immune Checkpoint Inhibitors
83 articles · page 5 of 7…Background With expanding use of immune checkpoint inhibitors, the incidence of immune-related adverse events (irAE) is on th…
…77.0412Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J M…
…SCLC) patients receiving neoadjuvant chemotherapy combined with immune checkpoint inhibitors (ICIs).Methods Cases meeting inclusion criteria were divided in…
…patient response to cancer immunotherapies. Cellular therapies, immune checkpoint inhibitors, and other modalities are limited for most solid tumors, especi…
…-threatening malignancy with limited therapeutic options. While immune checkpoint inhibitors have emerged as a promising avenue in HCC treatment, the clinic…
…Background Although immune checkpoint inhibitors (ICIs) have demonstrated success in several solid tumors, response am…
…heckpoint inhibitors (ICIs) in lung cancer patients. Currently, ICIs are the most effective treatment for late-stage lung cancer; ho…
… immunotherapies, including novel immune checkpoint inhibitors, bispecific antibodies, immune cell therapies, and advanced manufacturing technologies…
…Background Immune checkpoint inhibitors have significantly improved survival for melanoma patients, yet…
… given restricted success of immune-based approaches focused on Immune Checkpoint Inhibitors or Adoptive Cell Therapies. This underscores the urgent need fo…
….Conclusions These results highlight the potential of targeting DKK1 in combination with ICI therapies, to enhance NK cells activati…